Holen Sie sich die Stockscreener-App
16.98
2.44%
-0.415
Schlusskurs vom Vortag:
$17.40
Offen:
$17.3
24-Stunden-Volumen:
622.20K
Relative Volume:
0.21
Marktkapitalisierung:
$4.04B
Einnahmen:
$474.17M
Nettoeinkommen (Verlust:
$208.93M
KGV:
20.00
EPS:
0.8493
Netto-Cashflow:
$65.61M
1W Leistung:
-1.94%
1M Leistung:
-12.90%
6M Leistung:
-1.31%
1J Leistung:
+2.38%
1-Tages-Spanne:
$16.95
$17.74
1-Wochen-Bereich:
$16.62
$17.79
52-Wochen-Spanne:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Vergleichen Sie ADMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
16.98 | 4.14B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.63 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.34 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
811.57 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.84 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.19 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? - Finviz
High Growth US Tech Stocks To Watch In January 2026 - Yahoo Finance UK
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Campbell & CO Investment Adviser LLC Purchases Shares of 64,535 ADMA Biologics Inc $ADMA - MarketBeat
What are ADMA Biologics Inc.’s growth leversJuly 2025 Trends & Low Drawdown Investment Ideas - bollywoodhelpline.com
Can ADMA Biologics Inc. stock sustain free cash flow growthLayoff News & Community Consensus Trade Alerts - bollywoodhelpline.com
Will ADMA Biologics Inc outperform small cap indexesJuly 2025 Opening Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Retail Trends: Should I add ADMA Biologics Inc stock to my portfolio2025 Price Action Summary & Safe Capital Investment Plans - baoquankhu1.vn
ADMA Biologics reports preliminary 2025 results, ups 2026 outlook - MSN
Liquidity Mapping Around (ADMA) Price Events - Stock Traders Daily
ADMA Biologics, Inc. (ADMA): A Bull Case Theory - Finviz
ADMA Biologics: Business Update And My Price Target (NASDAQ:ADMA) - Seeking Alpha
Adma Biologics (ADMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - sharewise.com
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? - sharewise.com
Breakout Zone: Whats the beta of ADMA Biologics Inc stock2025 Key Lessons & Safe Entry Momentum Stock Tips - baoquankhu1.vn
ADMA’s Upgraded Multi‑Year Revenue Targets Might Change The Case For Investing In ADMA Biologics (ADMA) - Sahm
ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook - sharewise.com
How ADMA’s Multi‑Year Revenue Targets And Margin Push At ADMA Biologics (ADMA) Has Changed Its Investment Story - Yahoo Finance
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 8.7%Should You Sell? - MarketBeat
A Look At ADMA Biologics (ADMA) Valuation After Raised Guidance And New Long Term Growth Targets - Yahoo Finance
A Look At ADMA Biologics (ADMA) Valuation After New 2025–2027 Guidance And SG-001 Progress - Sahm
ADMA Biologics Highlights $510M+ 2025 Revenue, Raises 2027 Outlook at JPM Healthcare Conference - MarketBeat
Is ADMA Biologics (ADMA) Still Attractive After Recent Share Price Pullback - Yahoo Finance
ADMA Biologics Updates 2025, 2026 Revenue Outlook; 2027 Guidance Issued - marketscreener.com
ADMA Biologics (ADMA) Projects Strong Revenue Growth Through 202 - GuruFocus
ADMA Projects Strong Growth Momentum Heading Into 2026 - GuruFocus
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update - The Manila Times
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides ... - Bluefield Daily Telegraph
Infection-fighting drug data powers ADMA Biologics’ big growth plans - Stock Titan
ADMA Biologics Inc (ADMA) Investor Outlook: Exploring a 42.99% Potential Upside in Biotech - DirectorsTalk Interviews
ADMA Biologics (ADMA): Firm updates 2025 revenue guidance - MSN
Peregrine Capital Management LLC Purchases 73,868 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics raises FY25 revenue view to at least $510M from at least $500M - MSN
Can ADMA Biologics Inc. stock beat analyst upgrades2025 Earnings Impact & Proven Capital Preservation Tips - Улправда
ADMA Biologics Sees Unusually High Options Volume (NASDAQ:ADMA) - MarketBeat
Will ADMA Biologics Inc. stock gain from lower inflationWeekly Trade Report & Risk Managed Investment Entry Signals - ulpravda.ru
ADMA Biologics IncCommon Stock (NQ:ADMA) - FinancialContent
What momentum indicators show for ADMA Biologics Inc. stock2025 Momentum Check & Weekly High Return Opportunities - ulpravda.ru
Bear Alert: Can ADMA Biologics Inc. stock sustain free cash flow growth2025 Macro Impact & Daily Risk Controlled Trade Plans - ulpravda.ru
How ADMA Biologics Inc. stock valuations compare to rivalsDividend Cut Warnings & Fast Profit Trading Tips - Улправда
Published on: 2026-01-07 18:06:07 - ulpravda.ru
Nicholas Investment Partners, LP's ADMA Biologics Inc(ADMA) Holding History - GuruFocus
2026 world cup team news comparison: Will ADMA Biologics Inc. stock outperform growth indexes2026 world cup usa national team semifinals goalkeepers counter attacking tactical prediction preview - ulpravda.ru
Why Adma Biologics (ADMA) Outpaced the Stock Market Today - Yahoo Finance
A Look At ADMA Biologics (ADMA) Valuation As J.P. Morgan Healthcare Conference Presentation Nears - Sahm
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026 - The Manila Times
Why (ADMA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Allspring Global Investments Holdings LLC Sells 1,772,112 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Sold by Calamos Advisors LLC - MarketBeat
Does Kizi Apparels Limited Have a Competitive Advantage in Its SectorREITs Market Trends & Free Popular Stock Picks Selection - earlytimes.in
ADMA Biologics Earnings Notes - Trefis
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.38%
1.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):